Chemicals in green tea and red wine may block the brain damage caused by Alzheimer’s disease, an early study suggests.

Scientists targeted a process that allows harmful clumps of protein in the brain to kill off neurons.

Using purified extracts of the chemicals EGCG in green tea and resveratrol in red wine, they were able to stop nerve cells from being harmed.

The findings, published in the Journal of Biological Chemistry, could pave the way for new drugs to treat Alzheimer’s, say the researchers.

Lead scientist Professor Nigel Hooper, from the University of Leeds, said: “This is an important step in increasing our understanding of the cause and progression of Alzheimer’s disease.

“It’s a misconception that Alzheimer’s is a natural part of ageing; it’s a disease that we believe can ultimately be cured through finding new opportunities for drug targets like this.”

Alzheimer’s is characterised by a build-up of amyloid-beta protein in the brain which clumps together to form toxic, sticky balls.

The amyloid balls latch on to molecules called prions on the surface of nerve cells. As a result, the nerve cells start to malfunction and eventually die.

“We wanted to investigate whether the precise shape of the amyloid balls is essential for them to attach to the prion receptors, like the way a baseball fits snugly into its glove,” said Jo Rushworth, another member of the Leeds team. “And, if so, we wanted to see if we could prevent the amyloid balls binding to prion by altering their shape, as this would stop the cells from dying.”

Previous research had shown that the red wine and green tea compounds are able to reshape amyloid proteins.

When they were added to amyloid balls in a test tube, the toxic clumps of protein no longer harmed human and animal brain cells.

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.